Abstract Book March 28, 29 & 30 2011 Amsterdam The Netherlands European Conference TOBACCO or HEALTH Shape the future for a smoke free future Program at a glance Monday 28 March PAGE 9.15-9.40 Conference opening 9.40-10.30 Plenary speaker Laurent Huber: Implementing FCTC guidelines in Europe, how are we doing? 10.30-11.00 Coffee break 11.00-11.50 Plenary speaker Anna Gilmore: Countering smokefree hospitality in Europe, tobacco industry strategies to undermine smoke free legislation in Europe. 11.50-13.30 Lunch & posters - Policy related poster presentations 193 13.30-15.00 Parallel sessions 1 5 15.00-15.30 Coffee break 15.30-17.00 Parallel sessions 2 38 17.30-21.30 MIRO conference: The state of the art and challenges in smoking cessation: United Kingdom vs the Netherlands 18.30-21.30 Ladies film night in Tuschinski Theater playing Vicky Christina Barcelona - smoking in movies Tuesday 29 March 7.00-8.45 Pfizer breakfast symposium: EQUIPP on FCTC article 14 9.00-9.10 Welcome day 2 9.10-9.55 Plenary speaker Johan Mackenbach: the Netherlands Epidemiology of social inequalities in smoking/tobacco related health disparities. 9.55-10.45 Plenary speaker Amanda Amos: Reaching the unreachable, disadvantaged populations. 10.45-11.15 Coffee break 11.15-12.45 Parallel sessions 3 71 12.45-14.00 Lunch & posters - Intervention related poster presentations 259 14.00-15.30 Parallel sessions 4 101 15.30-16.00 Coffee break 16.00-17.30 Parallel Sessions 5 139 18.30-0.00 Dinner buffet, the Chain of Fools and surprise acts and award winning ceremony ECL/ECToH Young Professional award Wednesday March 30 9.00-9.10 Welcome day 3 9.10-10.30 Plenary session: Case study and disucssion on interference of tobacco industry in policy and science 10.30-11.15 Plenary speaker Neil Collishaw: A supply-side approach to tobacco control. 11.15-11.30 Coffee break 11.30-13.00 Parallel sessions 6 169 13.00-14.00 Lunch 14.00-15.15 Plenary ‘Shape The future’ session 15.15-15.45 Plenary speaker Florence Berteletti-Kemp: FCTC and beyond, emerging new policy options. 15.45-16.00 Closing of the conference 3 Parallel Sessions Symposia and oral presentations 4 Parallelsessions 1 Monday March 28, 13.30-15.00 1A - Symposium: The monitoring of Tobacco Control Policies in Europe at country level: the tobacco control scale Chair: Luk Joossens, Advocacy Officer, Association of European Cancer Leagues, Tobacco Control Expert, Belgian Foundation against Cancer Introductory presentation: Wendy Yared, Director, Association of European Cancer Leagues: Presentation of the updated 2010 TCS scores in Europe The Tobacco Control Scale quantifies the implementation of tobacco control policies at country level and is based on six policies described by the World Bank, which they say should be prioritized in a comprehensive tobacco control program. The six policies are: • price increases through higher taxes on tobacco products; • bans on smoking in public and work places; • better consumer information, including public information campaigns, • comprehensive bans on the advertising and promotion of all tobacco products, • large, direct health warning labels on tobacco products; • treatment to help dependent smokers stop, including increased access to medications TCS scores, reflecting the tobacco control policies in 30 European countries, exist for the years 2004, 2005 and 2007 and updated 2010 scores will be released one week before the ECTOH conference in Amsterdam in March 2011. The purpose of the symposium would be to discuss the monitoring of tobacco control policies at country level and the use of the Tobacco Control Scale in the past, present and future. Interactive panel discussion on the use of the Tobacco Control Scale in the past, present and future with the participation of: • Greece: Panagiotis Behrakis (President ENSP): the perspective of a high smoking prevalence country • Germany, German Cancer Research Center, Heidelberg : Martina Pötschke-Langer: the perspective of a country with a well organized tobacco industry lobby • United Kingdom, UK Centre for Tobacco Control Studies, University of Nottingham: Ann McNeill: the perspective of a country with a high TCS score • Turkey, Turkish Coalition on Tobacco or Health, Elif Dagli : the perspective of a high smoking prevalence country which has introduced recently important tobacco control legislation • European Commission, TBC : the perspective of DG SANCO on the monitoring of tobacco control policies at national level • Smoke Free Partnership: Florence Berteletti Kemp, Director: the perspective of an European campaigner on the monitoring of tobacco control policies at national level Parallelsessions 1: March 28, 13.30-15.00 5 Questions to panelists: • Does the TCS reflect the tobacco policy in your country? • Does the publication and the ranking have an impact on the policy in your country? • What will be the priorities of tobacco control in your country and in Europe in 2015? • The 100 points of the TCS does not include points on the tobacco industry interference on public health (FCTC article 5.3). How do we monitor article 5.3? Should we include article 5.3 in the next TCS? Title Tobacco Control Policies in Europe in 2010: The Tobacco Control Scale. Author Dr Wendy Yared, Director Association of …uropean Cancer Leagues Objective Monitoring tobacco control policies in Europe Methods Results of a survey of tobacco control activities in 31 European countries in 2010, using the Tobacco Control Scale (TCS), first described in our 2006 paper, The Tobacco Control Scale: a new scale to measure country activity. The TCS, which quantifies the implementation of tobacco control policies at country level, is based on six policies described by the World Bank, which they say should be prioritized in a comprehensive tobacco control programme. The six policies are: 1) price increases through higher taxes 2) smoke free public and work places 3) better consumer information, including public information campaigns, media coverage 4) comprehensive bans on the advertising and promotion 5) large, direct health warning labels 6) treatment to help dependent smokers stop Results The 31 countries are ranked by their total score on the scale out of a maximum possible score of 100 based on tobacco control policies in 2010. Conclusion A comparison will be made between tobacco control activities in 2007 and 2010. Implementation Based on the results of the TCS in 2010, recommendations will be made on tobacco control activities and research projects for the period 2010-2015 in Europe. Parallelsessions 1: March 28, 13.30-15.00 6 1B - Session Cessation tools 1B.1: The impact of the introduction of smokefree legislation on prescribing of stop-smoking medications in England L.C. Szatkowski, S.L. Lewis, A.M. McNeill, T.C. Coleman University of Nottingham, NOTTINGHAM, United Kingdom Objectives Survey findings suggest that the introduction of smokefree legislation may lead to short-term increases in smokers attempting to quit, though little is known about the pathways through which this happens. Ensuring smokers are offered, and access, the cessation support available through primary care may be one way to maximise the impact of smoking bans. This study uses data from The Health Improvement Network (THIN), a large database of primary care records, to investigate whether there were changes in the rate of prescribing of smoking cessation medications in the months leading up to, and after, the introduction of smokefree legislation in England in 2007. Methods Monthly rates of prescribing of NRT and bupropion were calculated from THIN from 2001 to 2009 for all smokers aged 16+ and for subgroups defined by patient sex, age group, history of chronic disease and quintile of the Townsend Index of Deprivation. ARIMA interrupted time series analysis was used to model these monthly rates and assess whether there were changes in prescribing before and after the introduction of smokefree legislation above and beyond any long-term and seasonal trends. Results A 7.3% increase in NRT prescribing and a 13.2% increase in bupropion prescribing occurred in the three months before smokefree legislation was introduced in England, and a 5.5% decline in NRT prescribing and a 13.7% decline in bupropion prescribing in the nine months post-legislation. These declines were offset to an extent, but not completely, by an increase in prescribing of varenicline which was first available on prescription in December 2006. The patterns of change in prescribing do not differ by patient sex, age group, medical history or social class. Conclusions The impending introduction of smokefree legislation may have caused some smokers to seek cessation support from primary care, or a doctor to offer unsolicited support to quit. However, there appears to have been a temporal displacement of quitting behaviour rather than an increase in the overall volume of quitting activity - during 2007, quit attempts which otherwise might have been made later in year appear to have been brought forward. The similar results in all population subgroups suggest that the changes in prescribing will neither widen nor reduce the health inequalities caused by smoking. Implementation Promoting and ensuring the availability of cessation support through primary care both before and after smokefree legislation is enacted may help to maximise the impact of a smoking ban. Parallelsessions 1: March 28, 13.30-15.00 7 1B.2: Psychological determinants of using evidence based smoking cessation aids in the Netherlands R.A. Willems1, M.C. Willemsen2, H. De Vries1 1Maastricht University, MAASTRICHT, The Netherlands 2STIVORO, the Dutch expertise centre for Tobacco Control, D…N HAAG, The Netherlands Objectives The utilization of effective cessation aids, such as professional help and pharmaceutics, will increase the likelihood of successful quitting. In the Netherlands, there is a wide array of effective smoking cessation aids available.